Outlook Therapeutics
OTLK
#8615
Rank
โ‚ฌ0.11 B
Marketcap
4,81ย โ‚ฌ
Share price
-1.95%
Change (1 day)
-42.92%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -โ‚ฌ86.78 Million

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ49.3 Million, an increase over its 2022 earnings that were of -โ‚ฌ67.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ86.78 Million76.05%
2023 -โ‚ฌ49.3 Million-26.7%
2022 -โ‚ฌ67.25 Million32.13%
2021 -โ‚ฌ50.9 Million46.21%
2020 -โ‚ฌ34.81 Million-18.82%
2019 -โ‚ฌ42.88 Million16.62%
2018 -โ‚ฌ36.77 Million57.88%
2017 -โ‚ฌ23.29 Million-56.17%
2016 -โ‚ฌ53.14 Million-9.26%
2015 -โ‚ฌ58.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.11 Billion 21.71% Jersey
-โ‚ฌ0.27 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ13.39 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ69.94 Million-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK